Juan Ramon
Gimeno Blanes
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Universidad Francisco de Vitoria
Pozuelo de Alarcón, EspañaPublicacions en col·laboració amb investigadors/es de Universidad Francisco de Vitoria (15)
2024
-
Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction
Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404
2022
-
Characterization of hereditary transthyretin cardiac amyloidosis in Spain
Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 488-495
-
Natural History of MYH7-Related Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461
-
Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
PloS one, Vol. 17, Núm. 2, pp. e0263140
-
Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
PLoS ONE, Vol. 17, Núm. 2 February
-
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
European Journal of Preventive Cardiology, Vol. 29, Núm. 4, pp. 645-653
2021
-
Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 78, Núm. 17, pp. 1682-1699
-
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662
2020
-
Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis
Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197
-
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene
Circulation: Heart Failure, Vol. 13, Núm. 10, pp. E006832
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 396, Núm. 10253, pp. 759-769
-
Mortality among Referral Patients with Hypertrophic Cardiomyopathy vs the General European Population
JAMA Cardiology, Vol. 5, Núm. 1, pp. 73-80
2019
2017
-
Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
International Journal of Cardiology, Vol. 248, pp. 232-238
2016
-
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Journal of the American College of Cardiology, Vol. 68, Núm. 22, pp. 2440-2451